The Medicine Box: Kiran Mazumdar-Shaw on biosimilar interchangeable status for Biocon’s diabetes drug

25-Nov-2021

Biocon Biologics, Viatris confirm offering steep savings on long-acting insulin through Walgreens Prescription Savings Club

19-Nov-2021

Walgreens to sell Biocon’s insulin Semglee in the U.S.

19-Nov-2021

Biocon Biologics, Viatris launch interchangeable insulin biosimilar for US

 16-Nov-2021

Biocon starts campaign to treat diabetic children, train healthcare workers

 15-Nov-2021

Access to diabetes care: If not now, then when?

 14-Nov-2021

Biocon Rating: Hold – Vaccines to complement biosimilar portfolio

 20-Sep-2021

Biocon Biologics, Serum Institute Life Sciences announce strategic alliance

 20-Sep-2021

Biocon jumps into vaccines through $4.9bn Serum Institute pact

 20-Sep-2021

Can Serum deal provide a booster dose to Biocon’s target price?

 20-Sep-2021

Interchangeable insulin to help us compete with big insulin makers: Kiran Mazumdar-Shaw

 29-Aug-2021

Vaccines alone will not protect and make the world safer: Biocon chief

 30-Jul-2021

India must use, share Covid data transparently: Kiran Mazumdar-Shaw

 26-Jul-2021

Biocon partners Adagio for licence to make Covid-19 antibody cocktail

 26-Jul-2021

Biocon eyes market share expansion in developed, emerging markets: Kiran Mazumdar-Shaw

 23-Jul-2021

Biocon Q4 profit more than doubles to Rs 254 crore

 29-Apr-2021

Shreehas Tambe named Deputy CEO of Biocon Biologics

 02-Mar-2021

Biocon Biologics, Viatris get CHMP nod for Abevmy

 02-Mar-2021